We have a diverse management team

The Core Team

Kelvin Chiu

Chief Executive Officer (CEO)

Kelvin has over 20 years of various academic and business experiences in biomedical industry.  He received his bachelor’s degree in biochemistry from UCLA, M.Phil.’s degree in molecular biology from The University of Hong Kong and MBA degree from UCLA Anderson School of Management, USA.

Kelvin worked at internationally leading organisations such as Children’s Hospital Los Angeles, Life Technologies.

Dr. Isabelle Dutry

Chief Scientific Officer (CSO)

Isabelle has over 15 years of international infectious disease research experience and worked in Institute Pasteur during the SARS and avian influenza outbreaks. She has a PhD in Microbiology at The University of Hong Kong and focused on Respiratory, Virology and Immunology studies.

Isabelle has been our key member as scientific principal since the early stage of foundation.

Peter Ying CGMA, CPA

Chief Financial Officer (CFO)

Peter has over 10 years of financial management, internal controls, corporate finance and financial reporting experience.

He is a member of the Hong Kong Institute of Certified Public Accountants and the Chartered Institute of Management Accountants, and acts as an Independent Non-Executive Director for Victory Securities Company Limited (8540 : HK).

Siu Mei Lee​

GENERAL MANAGER​

Siu Mei has been working for 25 years in corporate governance and policy, financial and logistics management, and human resources.

Edward Chu

Director of Operations

Edward has more than 20 years of experiences in manufacturing operations, technology transfer, quality control and other related fields, and more than 15 years of management experience in the biotechnology industry.

Prior to joining our team, Edward was responsible for the production of IVD products for QIAGEN (Germany).

Vincent Lam

Engineering Director

Vincent completed his Master of Science in Mechanical Engineering from The Ohio State University, Columbus USA, and he is a senior engineer with 25 years of experience. 

Prior to joining our team, he was senior engineer at Raytheon Company, Senior engineer at Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI), and engineering designer at Philips Electronics Hong Kong Limited.

Barry Leung

QUALITY ASSURANCE MANAGER

Barry is a professional quality assurance lead with a history of working experience in QA/QC fields for more than 20 years. Skilled in ISO and GMP auditing, new plant development and build-up of Quality Management System.

Safeguarding the quality by improving the standards in manufacturing and quality systems.

Janet Li

Marketing and BD Manager

Janet has scientific and industrial knowledges with various experiences of sales & marketing management and business strategy in medical device industry. She holds a master’s degree in biomedical engineering from the Hong Kong Polytechnic University.

With her research focusing on developing innovative diagnostic biosensor with nanomaterials. Janet brings to Sanwa her academic backgrounds of both science and engineering in industrial research and business model, sales and marketing execution, product launch, communication and partnership, operation management and problem-solving.​

Lok Choi

Assay Development Manager

After completing a Master of Health Sciences and a Master of Science at The University of Auckland, New Zealand, Lok became a Product & Process Scientist in a bioprocessing plant in New Zealand.

He developed manufacturing processes for various FDA and CE-IVD registered IVD controls for major players in the global IVD market.

Prior to that, he worked in Antibody & Immunoassay Services – the commercial sector of the State Key Laboratory for Pharmaceutical Biotechnology based in the University of Hong Kong.

Dr. Shao Wei

SENIOR SOFTWARE ENGINEER

Shao Wei got her PhD from Nanyang Technological University, Singapore. Before moving to Hong Kong, she has over 10-year experience on the product software in medical device and in vitro diagnostics industry in Singapore, including Biobot Surgical, Veredus Laboratories and etc.

Dr. Veronica Wong

Regulatory Affairs Manager

Veronica comes from a strong chemistry research background. She holds a MChem from Durham University, with her research focusing on alkali-doped fulleride superconductors.

Veronica also holds a PhD from the University of Cambridge, specialising in using solid-state nuclear magnetic resonance for biological material structural elucidation and to probe protein molecular dynamics.
She right now focuses on internal audits, regulatory strategies, and clinical trial management.

Witson Cheng

SENIOR ENGINEERING MANAGER

Witson has comprehensive knowledge in electronic hardware and software design, extensive experience in the field of electronic appliance R&D and manufacturing. He is also a certified six sigma black belt professional.

He is focusing on platform R&D projects and setup automatic production lines for BioChip manufacturing expansion.

Our Global Talents

0 +
Indirect
0 %
R&D Team: Master or PhD
0 :5
Gender Ratio (F:M)
0
Offices and Labs Worldwide
0 +
Nationalities
Board of Directors​

William Yim

Chairman, Founder

Mr. William Yim

William is the Founder and Chairman of ALiA BioTech Group. He is an active industrialist, technologist and inventor. He has intensive knowledge in electronics, optics, precision mechanics and advanced manufacturing technologies.

William has several inventions in communications, consumer electronics, and biotechnology, including ALiA® Microfluidic Lab-On-Chip based Point Of Care Testing Platform. He holds over 80 patents and has received many local and international design / invention awards, including Hong Kong Awards for the Industries in product design and technology achievement, and a gold award at Salon International Des Inventions Geneva.

Kelvin Chiu​

 Director

Kelvin Chiu​

Kelvin has over 20 years of various academic and business experiences in biomedical industry.  He received his bachelor’s degree in biochemistry from UCLA, M.Phil.’s degree in molecular biology from The University of Hong Kong and MBA degree from UCLA Anderson School of Management, USA.

Kelvin worked at internationally leading organisations such as Children’s Hospital Los Angeles, Life Technologies.

Wong Ming Yam, SBS, BBS, JP

Non-Executive Director

Wong Ming Yam, SBS, BBS, JP
Honorary Fellow ( CityU HK )

Wong Ming-yam, SBS, BBS, JP serves as Director or NED of a number of technology companies. Prior to this, he was the Senior Vice-President of Philips Electronics.

Passionate about innovation and technology development, he has actively served society through membership of several Government Boards and Committees for more than 35 years. He has been Member of the Assessment Panel of SERAP of ITC; Member and Deputy Chairman of the HKPC; Director of the HK Science & Technology Parks Corporation; Chairman of HK ASTRI; Chairman of the CreateSmart Initiative Vetting Committee of CreateHK; and an Ex-officio Member of the Committee on Innovation, Technology and Re-industrialization of the HKSAR.

At present, M Y continues to contribute to a number of public service roles linked with Government’s Innovation and Technology initiatives. He is Member of Steering Committee on Research Themes and Topics of the Research Grants Council; Member of the Cyberport Advisory Panel; Member of ESS Assessment Panel under the ITF; Member of Awards Committee of HKAEE; and Chairman of the Departmental Advisory Committee, Department of EE of City University.

Joey Ying

Vice Chairman, Director

Joey Ying (MSc)

Joey is an expert with over 40 years of experience in the field of environmental engineering. He is currently the president of ECCO Engineering Co Ltd and Beijing Envirotec Co Ltd. 

He was formerly managing director of Veolia Water Systems China Ltd and USFilter China Ltd.  In his earlier career, he was a consultant of The Hong Kong Productivity Centre, providing environmental control solutions to local industries.  Joey is a Hong Kong delegate of Tianjin Municipal Committee in the Chinese People’s Political Consultation Conference.

He holds a BSc degree in Biology & Biochemistry (CUHK) and a Master degree in Environmental Engineering (AIT). 

Sam Ng

Director

Sam Ng

Sam is the President of Max Choice which offers international health food. He has engaged in fine food industry for over 30 years. With his expertise in fine food and strong entrepreneur spirit, he distributed his franchise business throughout Hong Kong.

He has rich experience in public relationship and marketing. Also he has a strong network in media relations and sales promotion.

With his successful story rich operation management experiences, Sam is striving to incubate Hong Kong talents and technologies.

Advisory Committee

Technical & Scientific Advisory Committee

Prof. C. K. Michael Tse

Institute: City University of Hong Kong

Position: Associate Head and Chair Professor, Department of Industrial and Systems Engineering

Background:

  • BEng(Hons), PhD (Melbourne), FIEEE, FIEAust, University of Melbourne
  • Chang Jiang Scholars Chair Professor
  • Chair Professor of Electrical Engineering, City University of Hong Kong
  • Prior to joining City University in October 2019, Prof. Tse was the Head of the Department of Electronic and Information Engineering in the Hong Kong Polytechnic (2005-2012). He was also the Member of the University Council in 2013-2015.

Ir. Prof. K.L. Yung ,BBS

Institute: Hong Kong Polytechnic University

Position: Sir Sze-yuen Chung Professor in Precision Engineering; Chair Professor of Precision Engineering and Associate Head

Background:

  • Associate Head and Chair Professor, Department of Industrial and Systems Engineering, Hong Kong Polytechnic University
  • BSc, Electronic Engineering, Brighton University
  • MSc, DIC, Automatic Control Systems, Imperial College of Science, Technology & Medicine, University of London
  • PhD, Microprocessor Applications Process Control, Plymouth University
  • Chartered Engineer (CEng, MIEE)

Prof. CHEAH, Kok Wai

Institute: Hong Kong Baptist University

Position: Head/Professor, Department of Physics

Background:

  • Associate Director, Centre for Advanced Luminescence Materials, Hong Kong Baptist University
  • B.Sc. Hon degree, Physics, Imperial College, London, UK
  • M. Sc and DIC, Science of Materials, Imperial College, London, UK
  • Ph. D., Electrical and Electronic Engineering, Imperial College, London, UK
  • Honorary Associate Professor, The University of Hong Kong
  • Member of Institute of Physics (Chartered Scientist, Chartered Physicist) and Hong Kong Physical Society

Prof. Ka Ming NG

Institute: Hong Kong University of Science and Technology

Position: Professor Emeritus, Department of Chemical and Biological Engineering

Background:

  • Former CEO of NAMI
  • Professor Emeritus, Department of Chemical and Biological Engineering

Research Interests:

  • Development of processes with multiphase reactions, separation and purification using extraction and crystallization, solids processing
  • Applications in manufacture of pharmaceuticals and specialty chemicals

Research Area:

  • Advanced Materialm
  • Environmental engineering
  • Product and process systems engineering

Prof Poon, Lit Man Leo

Institute: The University of Hong Kong

Position: Professor and Division Head Division of Public Health Laboratory Sciences

Background:

  • Professor and Division Head, Division of Public Health Laboratory Sciences
  • BSc(HKBU), MPhil(CUHK), DPhil(Oxon), FFPH (UK)
  • Professor Poon has strong interests that are related to emerging viruses, ranging from studying basic biology of RNA viruses to developing molecular diagnostic tools for infectious diseases. His work primarily focuses on influenza virus and coronavirus. He published over 200 peer-reviewed articles. He is a founding member of the Hong Kong Young Academy of Sciences. He was awarded a Senior Research Fellowship by the Croucher Foundation in 2017. He has been ranked in the top 1% of the world’s most-cited scientists each year since 2005 by Clarivate Analytics (Total number of citations: 21762; H-index: 70) and, an even more prestigious honour, as a Highly Cited Researcher from 2015-2019.

  • Professor Poon involves in influenza research for over 20 years. He studied the replication and transmission of this virus. He developed several molecular tests for emerging avian influenza viruses (e.g. H5N1, pandemic H1N1/2009 and H7N9).

  • Professor Leo Poon received his doctoral training in Sir William Dunn School of Pathology in University of Oxford (1996-1999). After his graduation, he returned to Hong Kong and worked as a postdoctoral fellow in the Chinese University of Hong Kong (1999-2001). He joined the University of Hong Kong as a Research Assistant Professor in 2001. He currently serves as a Professor in the School of Public Health, HKU.

Strategic & Business Development Committee

Dr. Lewis Chan

Institute: Maunakai Capital Partners (Hong Kong) Ltd.

Position: Managing Partner

Background:

  • Dr. Lewis Chan is currently Managing Partner at Maunakai Capital Partners.  He co-founded Symbior Energy, an alternative energy company, and also sits on the board of listed companies DT Capital and D&G Technology Holding.
  • In his past career, he was an Assistant Professor and adjunct Associate Professor of Finance at The Hong Kong University of Science & Technology.
  • Dr. Chan received an undergraduate degree from the University of Chicago, a master degree from Columbia University and a doctorate from Harvard University.

Dr. Tin Yan Alvin Liu

Institute: Johns Hopkins University

 

Position: 

Assistant Professor of Ophthalmology; Johns Hopkins University School of Medicine

 

Director, Wilmer Precision Ophthalmology Center of Excellence; Johns Hopkins University School of Medicine

 

Affiliate Faculty, Malone Center for Engineering in Healthcare; Johns Hopkins University

 

Background:

  • Phillips Exeter Academy
  • Bachelor of Arts (B.A.); dual major in biology and economics; Cornell University
  • Doctor of Medicine (M.D.); Columbia University College of Physicians and Surgeons
  • Ophthalmology Residency; Wilmer Eye Institute Johns Hopkins University School of Medicine
  • Medical and Surgical Retina Fellowship; Wilmer Eye Institute Johns Hopkins University School of Medicine

 

Expertise:

  • Management of medical and surgical retinal diseases
  • Artificial intelligence
  • Digital health

Mr. Tony Li

Institute: Apple Inc.

Position: Former Director of Product Marketing

Background:

  • Tony is a seasoned marketeer with over twenty years of information technology and consumer electronics experiences across the Asia Pacific region. He worked at Apple for 23 years covering various senior management positions. Tony was the first marketing director for Apple China & Hong Kong region. His last post at Apple was the director of product marketing overseeing all product lines for Asia.
  • After Apple, Tony joined HTC as the Vice President of Marketing for Asia Pacific. Tony is now pursuing his own interests in helping startups, and in angel investments opportunities.
  • Graduated from the University of Technology and Science, Sydney, majoring in computing science and sub-majoring in finance.

Medical Advisory Committee

Dr. YU Cheuk Man

Institute: Hong Kong Baptist Hospital

Position:  Director, Heart Centre

Background:

  • Director, Heart Centre, Baptist Hospital
  • Professor, Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK)
  • Cardiologist, Prince of Wales Hospital, The Chinese University of Hong Kong (CUHK)
  • Director (Clinical Sciences), Institute of Vascular Medicine
  • Director, Heart Education And Research Training (HEART) Centre in CUHK
  • Prof. Yu has an extensive publication record of over 340 full scientific articles and reviews in referred journals. His work is frequently quoted by peer groups with a total citation of over 10,000, and with H-Index of 49. He has edited 10 books and authored over 30 book chapters.


Research Interests:

  • Prof. Yu has a board range of clinical and research specialization including echocardiography and cardiovascular imaging, device therapy, percutaneous coronary intervention, heart failure and structural heart disease intervention, and has participated in a large number of multicenter clinical trials.

Dr. Charles Chan

Institute: Virtus Medical Group

Position: Director of Business Development

Background:

  • Director, Health Concepts Ltd.
  • Executive Director, Genesis Healthcare Ltd.
  • Director of Business Development, Virtus Medical Group
  • Dr Chan is a shareholder of SBT and currently serves as the Director of Business Development of Virtus Medical Group Ltd., expanding the group’s comprehensive medical services in Guangdong-Hong Kong-Macau Greater Bay Area.

  • Dr Chan has 25 years of experience in managing medical institutions. He has extensive experience in clinic construction, system building, ISO certification, management of front-line medical staff, epidemic prevention and control, daily operations and crisis management.

  • Dr Chan served as the consultant to major universities in Hong Kong and major hotels and resorts in Macau, including Hong Kong University of Science and Technology, City University of Hong Kong, The Education University of Hong Kong, University of Macau, Sands Cotai Central, Galaxy Macau™, The Parisian Macao, etc. Dr Chan has also served as a consultant to major investment funds in the healthcare industry, providing professional advice on health-related projects in major cities of China.

Ms. Marianne Leung

Institute: PathLab Medical Laboratories Ltd.

Position: Lab Director

Background:

  • Lab Director, PathLab Medical Laboratory Ltd.
  • MT (ASCP), Creighton University
  • Ms Leung currently serves as Lab Director of PathLab Medical Laboratory Ltd., one of the best laboratory services providers in Hong Kong.

  • Ms Leung has 45 years of experience in clinical laboratory science and the medical technology industry. She has extensive experience providing clinical diagnostic laboratory testing services to professionals, medical laboratory construction, management of front-line medical staff, daily operations and crisis management.

  • Ms Leung has also served as Vice Chairman of The Hong Kong Association of Medical Laboratories Limited (HKAML), providing professional advice on medical laboratories in Hong Kong.

ALiA BioTech has a diverse and educated management team